Clinical variability and molecular heterogeneity in prostate cancer
Prostate cancer is a clinically heterogeneous disease, with some men having indolent disease that can safely be observed, while others have aggressive, lethal disease. Over the past decade, researchers have begun to unravel some of the genomic heterogeneity that contributes to these varying clinical...
Main Authors: | Jonathan Shoag, Christopher E Barbieri |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Asian Journal of Andrology |
Subjects: | |
Online Access: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=4;spage=543;epage=548;aulast=Shoag |
Similar Items
-
Molecular Cloning and Functional Studies of Two Kazal-Type Serine Protease Inhibitors Specifically Expressed by Nasonia vitripennis Venom Apparatus
by: Cen Qian, et al.
Published: (2015-08-01) -
Characterization and Gene Expression Analysis of Kazal-Type Serine Protease Inhibitors of Globisporangium ultimum
by: Maharjan, Ashok
Published: (2021) -
SPOP mutation leads to genomic instability in prostate cancer
by: Gunther Boysen, et al.
Published: (2015-09-01) -
Two cases of chronic pancreatitis associated with anomalous pancreaticobiliary ductal union and mutation
by: Eun Sam Rho, et al.
Published: (2013-05-01) -
SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair
by: Rihan El Bezawy, et al.
Published: (2020-06-01)